RCKT - Rocket Pharma Net earnings per share for the last 12 months

Symbol and logo of brand Rocket Pharmaceuticals, Inc. (RCKT)

Demand for gene therapy for pathologies is independent of GDP, rendering the sector non-cyclical. On GURU.Markets, this linear chart of TTM earnings per share demonstrates a sideways trend, where -0.16 indicates the current level. The Rocket Pharmaceuticals (RCKT) strategy is based on strict ESG bioethics, yet a narrow focus on rare diseases creates high binary risks due to the absence of commercial products.

RCKT Rocket Corp Earnings per one share for the last 12 months (07/04/2022 - 11/14/2026)

Summary analytical data breakdowns for Rocket Pharma (RCKT)

- share price and expert price forecast:
Stock Quotes Rocket Pharmaceuticals|RCKT - Analyst Forecast Prices
- market capitalization statistics:
Market Valuation Rocket Pharmaceuticals, Inc.|RCKT - Value Adjusted for Debt and Cash
- balance sheet net asset value indicators:
Net Assets per Single Share Rocket Pharmaceuticals|RCKT - Net Asset Value|Market Capitalization to Book Value Ratio rocketpharma.com|RCKT - Aggregate Asset Value
- debt obligations and liquidity statistics:
Total Debt to Capital Rocket Pharmaceuticals|RCKT - Long-Term Debt to Capital|Short-Term Debt to Equity Rocket Pharmaceuticals Inc|RCKT - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Rocket Pharmaceuticals, Inc.|RCKT - Company Long-Term Liabilities|Company Short-Term Debts Rocket Pharmaceuticals|Quick Ratio rocketpharma.com
- earnings and multiples data:
RCKT - Net Income|Projected Future Earnings Rocket Pharmaceuticals|RCKT - Market Cap to Earnings|Projected Price to Earnings Rocket Pharmaceuticals, Inc.|RCKT - PEG Multiple|Enterprise Value to EBITDA Ratio Rocket Pharmaceuticals, Inc.|RCKT - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Rocket Pharmaceuticals|RCKT - Net earnings per share for the last four quarters|Quarterly EPS earnings growth rocketpharma.com|RCKT - Net earnings per share growth this year|Earnings growth forecast for next year Rocket Pharmaceuticals
- company sales and revenue statistics:
RCKT - Revenue and Sales Volume|Company Projected Revenue Rocket Pharmaceuticals|RCKT - Price-to-Revenue Ratio|Price-to-Projected Revenue Ratio Rocket Pharmaceuticals, Inc.
General company analysis:RCKT - Rocket Pharmaceuticals
Manufactured products of Rocket Pharmaceuticals Inc

Fundamental asset selection requires an analysis of real earnings per share, which allows for an assessment of business efficiency regardless of the total issuance volume. This metric measures annual net profit, reflecting the ability of Rocket Pharmaceuticals (RCKT) to monetize its exclusive developments in the field of gene therapy for rare diseases, as clearly demonstrated by the 12-month net income per share chart.

Competitor analysis

TEM: Net earnings per share for the last 12 months|qiagen.com - Earnings per share for the last four quarters|IONS (Ionis) - Net earnings per share for the last 12 months|Repligen Corp - Earnings per share for the trailing year|Earnings per share for the last twelve months Avidity|CRISPR - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) WGS|RARE (ultragenyx.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) BEAM (Beam Therapeutics)|Net earnings per share (EPS TTM) Sarepta Therapeutics SRPT|TWST - Earnings per share for the last twelve months|Earnings per share for the trailing year TXG (10x)|Intellia Therapeutics (NTLA) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months stoketherapeutics.com|BLFS (BioLife Solutions) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Wave Life Sciences Ltd|Net earnings per share (EPS TTM) MAZE|Net earnings per share for the last 12 months Sionna Corp SION|Net earnings per share (EPS TTM) PRME (Prime Medicine, Inc.)|tayshagtx.com (TSHA) - Net earnings per one share for the last twelve months|QURE: Net earnings per share for the last 12 months|MGTX - Net earnings per share (EPS TTM)|RGNX (Regenxbio) - Net earnings per share for the last 12 months|SLDB: Earnings per share for the last four quarters|OCGN (Ocugen, Inc.) - Net earnings per share (EPS TTM)|pacb.com (PACB) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BNTC|Net earnings per share for the last 12 months Design Therapeutics Inc DSGN|Net earnings per share (EPS TTM) FDMT (4D Molecular Therapeutics Inc)|Net earnings per share (EPS TTM) Lexeo Therapeutics Inc. LXEO|KRRO - Earnings per share for the last twelve months|EDIT: Earnings per share for the last twelve months|Silence Therapeutics plc (SLN) - Earnings per share for the last twelve months|PRQR - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Codexis Inc|SGMO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) NAUT|Net earnings per share for the last 12 months metagenomi.co MGX|Earnings per share for the last twelve months Precision BioSciences, Inc. DTIL|Net earnings per share (EPS TTM) Generation Bio Co GBIO|BOLD: Net earnings per share for the last 12 months|Exicure, Inc. - Earnings per share for the last four quarters|IMNN: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months PHIO|Earnings per share for the last twelve months Mustang Bio Inc|Earnings per share for the last 12 months RNAZ (TransCode)|Net earnings per share (EPS TTM) BNGO|Net earnings per share (EPS TTM) Applied DNA Corp (APDN)|Earnings per share for the last twelve months bluebird bio, Inc. BLUE|Earnings per share for the trailing year IPA|OMGA - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Singular Genomics Systems, Inc.|RGLS: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Syros Pharmaceuticals, Inc|Earnings per share for the last twelve months Telesis Bio, Inc.|Net earnings per share (EPS TTM) traconpharma.com|Net earnings per share (EPS TTM) UBX